Clinical Trial Transparency and Disclosure

Editorial

News from the EMA

Medical Writing. 2024;33(3):72–78

Anuradha Alahari

Clinical trial transparency and disclosure from the medical writing perspective

Medical Writing. 2024;33(3):2–4

Holly Hanson, Alison McIntosh

From the Editor

Medical Writing. 2024;33(3):6–7

Raquel Billiones

President's Message

President’s Message

Medical Writing. 2024;33(3):8

EMWA News

EMWA News

Medical Writing. 2024;33(3):10–11

Feature Articles

Creating educational materials about clinical research data for patients and the public: A multifaceted journey in the current digital age

Medical Writing. 2024;33(3):46–53

Devaki Thavarajah, Sylvia Baedorf Kassis, Alyssa Panton, Barbara E. Bierer, Trishna Bharadia

Making the leap: Transparency requirements for clinical trials moving from one regulatory framework to another

Medical Writing. 2024;33(3):22–25

Mirjana Miric, Sarah Bly

Medical writing in Italy in 2024: Results of the first Italian business and compensation survey

Medical Writing. 2024;33(3):62–70

Daniela Longo, Johanna M. Chester, Laura C. Collada Ali, Andrea Rossi

Navigating the complex landscape of clinical trial transparency: What medical writers need to know

Medical Writing. 2024;33(3):26–33

Pooja Phogat, Stuart Donald

Plain language summaries of clinical trial results: What is their role, and should patients and AI be involved?

Medical Writing. 2024;33(3):34–37

Lisa Chamberlain James

Protection of personal data and commercially confidential information under the Clinical Trials Regulation (EU) No. 536/ 2014 – EMA “Revised CTIS Transparency Rules"

Medical Writing. 2024;33(3):12–21

Merete Jørgensen, Kathy B. Thomas, Matthias Zerm, Robert A. Paarlberg

Publisher perspectives on plain language summaries of scientific publications: An Open Pharma survey

Medical Writing. 2024;33(3):54–61

Slavka Baronikova, Adeline Rosenberg, Christopher C. Winchester, Valérie Philippon, Jo Gordon, Joana Osório

The 2023 CORE Reference Utility Survey: Perceptions on a best practice tool for globally applicable clinical study reporting and provision of continuing professional development resources for the regulatory medical writing community

Medical Writing. 2024;33(3):38–45

Zuo Yen Lee, Alison McIntosh, Vivien Fagan, Sam Hamilton

Regular Sections

Digital Communication

Medical Writing. 2024;33(3):79–88

Nicole Bezuidenhout, Jacqueline Bersano

Good Writing Practice

Medical Writing. 2024;33(3):112

Wendy Kingdom, Amy Whereat, Michael Lewis Schneir

In the Bookstores

Medical Writing. 2024;33(3):102–103

Alison McIntosh, Pablo Izquierdo

Medical Communications and Writing for Patients

Medical Writing. 2024;33(3):89–93

Lisa Chamberlain James, Aki Yoshikawa, Atsuko Iwata, Miho Hatano, Yuko Kojima

Publications

Medical Writing. 2024;33(3):104–107

Regulatory Public Disclosure

Medical Writing. 2024;33(3):95–100

The Crofter: Sustainable Communications

Medical Writing. 2024;33(3):108–111

Louisa Ludwig-Begall, Sarah Kabani

Your cart is empty.